摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Dimethyl 2-[[methoxy-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropyl]phosphoryl]methyl]pentanedioate | 1446694-05-8

中文名称
——
中文别名
——
英文名称
Dimethyl 2-[[methoxy-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropyl]phosphoryl]methyl]pentanedioate
英文别名
dimethyl 2-[[methoxy-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropyl]phosphoryl]methyl]pentanedioate
Dimethyl 2-[[methoxy-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropyl]phosphoryl]methyl]pentanedioate化学式
CAS
1446694-05-8
化学式
C23H36NO8P
mdl
——
分子量
485.514
InChiKey
ARMRQOJKTSHGNW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    33
  • 可旋转键数:
    16
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    117
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Phosphinic acid-based inhibitors of tubulin polyglutamylases
    摘要:
    Tubulin is subject to a reversible post-translational modification involving polyglutamylation and deglutamylation of glutamate residues in its C-terminal tail. This process plays key roles in regulating the function of microtubule associated proteins, neuronal development, and metastatic progression. This study describes the synthesis and testing of three phosphinic acid-based inhibitors that have been designed to inhibit both the glutamylating and deglutamylating enzymes. The compounds were tested against the polyglutamylase TTLL7 using tail peptides as substrates (100 mu M) and the most potent inhibitor displayed an IC50 value of 150 mu M. The incorporation of these compounds into tubulin C-terminal tail peptides may lead to more potent TTLL inhibitors. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.05.069
  • 作为产物:
    描述:
    (1-(N-(tert-butyloxycarbonyl)amino)-3-phenylpropyl) phosphinic acid 在 三甲基硅烷化重氮甲烷 作用下, 以 乙醚甲苯 为溶剂, 反应 4.67h, 生成 Dimethyl 2-[[methoxy-[1-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropyl]phosphoryl]methyl]pentanedioate
    参考文献:
    名称:
    Phosphinic acid-based inhibitors of tubulin polyglutamylases
    摘要:
    Tubulin is subject to a reversible post-translational modification involving polyglutamylation and deglutamylation of glutamate residues in its C-terminal tail. This process plays key roles in regulating the function of microtubule associated proteins, neuronal development, and metastatic progression. This study describes the synthesis and testing of three phosphinic acid-based inhibitors that have been designed to inhibit both the glutamylating and deglutamylating enzymes. The compounds were tested against the polyglutamylase TTLL7 using tail peptides as substrates (100 mu M) and the most potent inhibitor displayed an IC50 value of 150 mu M. The incorporation of these compounds into tubulin C-terminal tail peptides may lead to more potent TTLL inhibitors. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.05.069
点击查看最新优质反应信息

文献信息

  • Phosphinic acid-based inhibitors of tubulin polyglutamylases
    作者:Yanjie Liu、Christopher P. Garnham、Antonina Roll-Mecak、Martin E. Tanner
    DOI:10.1016/j.bmcl.2013.05.069
    日期:2013.8
    Tubulin is subject to a reversible post-translational modification involving polyglutamylation and deglutamylation of glutamate residues in its C-terminal tail. This process plays key roles in regulating the function of microtubule associated proteins, neuronal development, and metastatic progression. This study describes the synthesis and testing of three phosphinic acid-based inhibitors that have been designed to inhibit both the glutamylating and deglutamylating enzymes. The compounds were tested against the polyglutamylase TTLL7 using tail peptides as substrates (100 mu M) and the most potent inhibitor displayed an IC50 value of 150 mu M. The incorporation of these compounds into tubulin C-terminal tail peptides may lead to more potent TTLL inhibitors. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多